Jérôme H. Kim

23.1k total citations · 3 hit papers
197 papers, 5.4k citations indexed

About

Jérôme H. Kim is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jérôme H. Kim has authored 197 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Virology, 98 papers in Infectious Diseases and 49 papers in Immunology. Recurrent topics in Jérôme H. Kim's work include HIV Research and Treatment (100 papers), HIV/AIDS Research and Interventions (33 papers) and Immune Cell Function and Interaction (32 papers). Jérôme H. Kim is often cited by papers focused on HIV Research and Treatment (100 papers), HIV/AIDS Research and Interventions (33 papers) and Immune Cell Function and Interaction (32 papers). Jérôme H. Kim collaborates with scholars based in United States, South Korea and Thailand. Jérôme H. Kim's co-authors include Jean‐Louis Excler, Nelson L. Michael, Florian Marks, Merlin L. Robb, John D Clemens, Mélanie Saville, Seth Berkley, Jintanat Ananworanich, Supachai Rerks‐Ngarm and Robert Paris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jérôme H. Kim

190 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Looking beyond COVID-19 vaccine phase 3 trials

2021 417 citations Jérôme H. Kim, Florian Marks et al. profile →
Vaccine development for emerging infectious diseases

2021 256 citations Jean‐Louis Excler, Jérôme H. Kim et al. profile →
Vaccines and therapeutics for immunocompromised patients with COVID-19

2023 66 citations Shmuel Shoham, Carolina Batista et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jérôme H. Kim United States	40	2.4k	2.0k	1.5k	1.1k	917	197	5.4k
Koleka Mlisana South Africa	40	4.3k 1.8×	2.8k 1.4×	1.6k 1.1×	2.4k 2.1×	933 1.0×	181	7.6k
Ravindra K. Gupta United Kingdom	36	5.0k 2.1×	1.9k 0.9×	759 0.5×	1.7k 1.5×	1.5k 1.6×	171	8.0k
Yuxian He China	50	9.0k 3.8×	3.0k 1.5×	2.2k 1.5×	1.6k 1.4×	2.4k 2.6×	153	11.9k
Marie Paule Kiény France	40	1.4k 0.6×	1.5k 0.7×	1.3k 0.9×	1.9k 1.7×	1.3k 1.4×	108	5.6k
Satish K. Pillai United States	38	2.8k 1.2×	2.0k 1.0×	949 0.6×	1.1k 1.0×	1.5k 1.6×	114	5.4k
Odile Launay France	39	2.6k 1.1×	666 0.3×	810 0.6×	3.3k 3.0×	406 0.4×	274	6.0k
Souleymane Mboup Senegal	54	5.3k 2.2×	4.4k 2.2×	1.4k 0.9×	3.0k 2.7×	824 0.9×	311	9.9k
Mahdad Noursadeghi United Kingdom	38	1.9k 0.8×	951 0.5×	1.4k 0.9×	1.6k 1.4×	1.3k 1.4×	121	5.0k
Mark J. Mulligan United States	46	3.6k 1.5×	2.4k 1.2×	3.2k 2.2×	3.2k 2.9×	1.8k 2.0×	150	8.5k
Penny L. Moore South Africa	38	2.8k 1.2×	3.2k 1.6×	2.0k 1.4×	848 0.8×	1.5k 1.6×	144	5.7k

Countries citing papers authored by Jérôme H. Kim

Since Specialization

Citations

This map shows the geographic impact of Jérôme H. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme H. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme H. Kim more than expected).

Fields of papers citing papers by Jérôme H. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme H. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme H. Kim. The network helps show where Jérôme H. Kim may publish in the future.

Co-authorship network of co-authors of Jérôme H. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme H. Kim. A scholar is included among the top collaborators of Jérôme H. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme H. Kim. Jérôme H. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jae Seung, Myung Hwa Chae, Ye Kang, et al.. (2025). Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine. Vaccine. 52. 126913–126913. 1 indexed citations

Emary, Katherine R. W., Adwoa Bentsi-Enchill, Birgitte Giersing, et al.. (2025). Landscape analysis of invasive non-typhoidal salmonella (iNTS) disease and iNTS vaccine use case and demand: Report of a WHO expert consultation. Vaccine. 55. 127008–127008. 1 indexed citations

Doubell, Anton, Christiane Gerke, Lesley A. Ogilvie, et al.. (2025). Vaccines and AMR: An analysis of the funding landscape for human bacterial vaccines in low-and middle-income countries. Vaccine. 49. 126771–126771. 1 indexed citations

Ahmmed, Faisal, Farhana Khanam, Md Taufiqul Islam, et al.. (2024). Spatial and temporal clustering of typhoid fever in an urban slum of Dhaka City: Implications for targeted typhoid vaccination. PLoS neglected tropical diseases. 18(6). e0012273–e0012273. 1 indexed citations

Yadav, Prashant, Carolina Batista, Ravi Anupindi, et al.. (2023). Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic. 2(2). 59–66. 1 indexed citations

Lee, Jung-Seok, et al.. (2023). Global economic burden per episode for multiple diseases caused by group A Streptococcus. npj Vaccines. 8(1). 69–69. 12 indexed citations

Lee, Jung-Seok, Vittal Mogasale, Jeffrey Cannon, et al.. (2023). The potential global cost-effectiveness of prospective Strep A vaccines and associated implementation efforts. npj Vaccines. 8(1). 128–128. 6 indexed citations

Shoham, Shmuel, Carolina Batista, Yanis Ben Amor, et al.. (2023). Vaccines and therapeutics for immunocompromised patients with COVID-19. EClinicalMedicine. 59. 101965–101965. 66 indexed citations breakdown →

Herrera, Carolina, Ronald S. Veazey, Melissa M. Lemke, et al.. (2022). Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human Primates. Vaccines. 10(2). 187–187. 1 indexed citations

10.

Im, Justin, Md Taufiqul Islam, Faisal Ahmmed, et al.. (2020). Can Existing Improvements of Water, Sanitation, and Hygiene (WASH) in Urban Slums Reduce the Burden of Typhoid Fever in These Settings?. Clinical Infectious Diseases. 72(11). e720–e726. 12 indexed citations

11.

Im, Justin, Md Taufiqul Islam, Deok Ryun Kim, et al.. (2020). Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata. PLoS neglected tropical diseases. 14(8). e0008530–e0008530. 3 indexed citations

12.

Liu, Feng‐Liang, Qingli Niu, Xiuzhen Fan, et al.. (2017). Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16–STING–Type I IFN Pathway and AIM2 Sensor. The Journal of Immunology. 199(9). 3293–3305. 31 indexed citations

13.

Hurria, Arti, Chie Akiba, Jérôme H. Kim, et al.. (2016). Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer. Journal of Oncology Practice. 12(12). e1025–e1034. 65 indexed citations

14.

Sachdev, Darpun, Hasan Ahmed, Yunda Huang, et al.. (2014). Sex Differences in Immune Variables in the RV144 Trial. AIDS Research and Human Retroviruses. 30(S1). A191–A191. 1 indexed citations

15.

Manrique, Amapola, Elizabeth M. Adams, Dan H. Barouch, et al.. (2014). The Immune Space: A Concept and Template for Rationalizing Vaccine Development. AIDS Research and Human Retroviruses. 30(11). 1017–1022. 10 indexed citations

16.

Pitisuttithum, Punnee, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.. (2014). RV306, an Evaluation of a 48 Week ALVAC-HIV AIDSVAX B/E Vaccination Regimen in Thailand: Participation Rates for Optional Specimen Collections. AIDS Research and Human Retroviruses. 30(S1). A264–A264. 4 indexed citations

17.

Hu, Haitao, Martin E. Nau, Philip K. Ehrenberg, et al.. (2012). Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. Blood. 121(7). 1136–1144. 35 indexed citations

18.

Kim, Jérôme H., Punnee Pitisuttithum, Thippawan Chuenchitra, et al.. (2003). Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1. AIDS Research and Human Retroviruses. 19(9). 807–816. 19 indexed citations

19.

Kim, Jérôme H., J D Mosca, Maryanne Vahey, et al.. (1993). Consequences of Human Immunodeficiency Virus Type 1 Superinfection of Chronically Infected Cells. AIDS Research and Human Retroviruses. 9(9). 875–882. 21 indexed citations

20.

Kim, Jérôme H. & Harry A. Gallis. (1989). Observations on spiraling empiricism: Its causes, allure, and perils, with particular reference to antibiotic therapy. The American Journal of Medicine. 87. 201–206. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact